Search results for "Urology & Nephrology"

showing 10 items of 361 documents

Predictive variables of spontaneous micturition recovery after acute urinary retention in men with benign prostatic enlargement: An observational pro…

2017

Objective: Acute urinary retention (AUR) is the sudden and painful inability to urinate spontaneously. AUR is one of the most significant complications of benign prostatic enlargement. The management of AUR is based on transurethral catheterization. Subsequent therapy is uncertain, but AUR seems to benefit from the use of alpha-blockers. The aim of this study was to evaluate the variables that could predict which patients would recover spontaneous micturition after trial without catheter. Methods: The present prospective observational study included men with AUR in an Italian tertiary care institute in 2016. Patients were catheterized and treated orally with fluoroquinolones, alpha-blockers…

Malemedicine.medical_specialtyNeurologymedia_common.quotation_subjectUrology030232 urology & nephrologyUrologyProstatic HyperplasiaUrinationUrinationSeverity of Illness IndexC-reactive protein03 medical and health sciences0302 clinical medicineProstatemedicineHumansProspective Studiesacute urinary retentionProspective cohort studymedia_commonAgedspontaneous micturition recoveryInternational Prostate Symptom ScorebiologyUrinary retentionbusiness.industryC-reactive proteinArea under the curveProstateOrgan SizeRecovery of FunctionMiddle AgedUrinary Retentionmedicine.anatomical_structureROC CurveNeurology030220 oncology & carcinogenesisArea Under CurveAcute Diseasebiology.proteinInternational Prostate Symptom Scoremedicine.symptombusinessUrinary Catheterization
researchProduct

Sildenafil orodispersible film in the treatment of erectile dysfunction after radical prostatectomy: A single‐centre open‐label uncontrolled trial

2020

Phosphodiesterase-5 inhibitors are the first-line therapy for erectile dysfunction (ED) after radical prostatectomy (RP). This single-centre open-label uncontrolled study evaluated the efficacy and safety of the new sildenafil orodispersible film (ODF) in ED treatment after RP. Sildenafil 100 mg ODF was administered twice a week for 3 months to patients under 75 years of age, with a Framingham cardiovascular risk score < 20% and a pre-operative International Index of Erectile Function (IIEF)-5 score ≥ 17, who had undergone open RP between 2016 and 2018. Erectile function was assessed pre-operatively, post-operatively and after treatment through the IIEF-5 score, the Sexual Encounter Prof…

Malemedicine.medical_specialtyPercentileSildenafilUrologymedicine.medical_treatment030232 urology & nephrologyUrologyUncontrolled Studyprostatic neoplasmsSildenafil Citrate03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyErectile DysfunctiontherapeuticsHumansMedicineAdverse effectProstatectomy030219 obstetrics & reproductive medicineFramingham Risk Scorebusiness.industryProstatectomyPenile ErectionOrodispersible filmGeneral MedicinePhosphodiesterase 5 Inhibitorsmedicine.diseaseTreatment OutcomeErectile dysfunctionchemistrybusinessAndrologia
researchProduct

Immune-unreactive urinary albumin as a predictor of cardiovascular events: The Hortega Study

2019

Background: We aimed to determine if immune-unreactive albumin excretion (IURAE) is associated with cardiovascular (CV) events in a representative sample of a general population from Spain.Methods: We included 1297 subjects (mean age ± standard error 48.0 ± 0.2 years, 48% females), who participated in the Hortega Follow-Up Study. The primary endpoint was incidence of fatal and non-fatal CV events. Urinary albumin excretion (UAE) was measured in spot voided urine, frozen at -80°C, by immunonephelometry [immune-reactive albumin excretion (IRAE)] and by high-performance liquid chromatography (HPLC) [total albumin excretion (AE)]. IURAE was calculated as the difference between HPLC measurements…

Malemedicine.medical_specialtyPopulation030232 urology & nephrologyUrineUrinalysis030204 cardiovascular system & hematologyGastroenterologyCohort StudiesExcretion03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePredictive Value of TestsAlbuminsInternal medicinemedicineAlbuminuriaHumansMass ScreeningeducationTransplantationeducation.field_of_studyCreatininebusiness.industryProportional hazards modelIncidenceIncidence (epidemiology)Hazard ratioMiddle AgedConfidence intervalchemistryCardiovascular DiseasesSpainNephrologyFemalebusinessBiomarkersFollow-Up Studies
researchProduct

Potential Candidates for Focal Therapy in Prostate Cancer in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Large Multicenter Cohort Study.

2020

Focal therapy (FT) with its favorable side-effect profile represents an option between active surveillance and traditional whole-gland treatment in localized prostate cancer (PCa). Consensus statements recommend eligibility criteria based on magnetic resonance imaging (MRI)-targeted and systematic combination biopsy.To estimate the future potential of FT by analyzing the number of men eligible for FT among all men with biopsy-proven PCa and to judge the potential of different energy sources.Consensus criteria on FT were analyzed. Patients with biopsy-proven PCa from six tertiary referral hospitals and one outpatient practice in Germany had received a software-based combination biopsy. Men w…

Malemedicine.medical_specialtyProstate biopsyUrologyBiopsy030232 urology & nephrologyCohort Studies03 medical and health sciencesProstate cancer0302 clinical medicineProstateBiopsyMedicineHumansmedicine.diagnostic_testbusiness.industryProstatic NeoplasmsMagnetic resonance imagingProstate-Specific Antigenmedicine.diseaseMagnetic Resonance Imagingmedicine.anatomical_structure030220 oncology & carcinogenesisProstate neoplasmRadiologybusinessEnergy sourceCohort studyEuropean urology focus
researchProduct

Antibiotic Coating of the Artificial Urinary Sphincter (AMS 800): Is it Worthwhile?

2016

Objective To investigate the impact of the antibiotic coating InhibiZone on the infection and explantation rates of the AMS 800 in comparison to the AMS 800 without InhibiZone. Materials and Methods We retrospectively identified 305 patients with an AMS 800 in a multicenter cohort study. Patients were subsequently divided into InhibiZone and without InhibiZone-coated groups. Infection and explantation rates were analyzed by univariate and consecutively by multivariate logistic regression adjusted to variable risk factors. The infection-free interval was estimated by Kaplan-Meier plot and compared by the log-rank test. A P value below .05 was considered statistically significant. Results We …

Malemedicine.medical_specialtyProsthesis-Related InfectionsMultivariate analysismedicine.drug_classUrologyAntibiotics030232 urology & nephrologyLong Term Adverse EffectsProsthesis DesignLogistic regressionRisk AssessmentGastroenterologyCohort StudiesArtificial urinary sphincter03 medical and health sciences0302 clinical medicineCoated Materials BiocompatibleRisk FactorsInternal medicineOutcome Assessment Health CaremedicineHumansAgedUnivariate analysisbusiness.industrySignificant differenceMiddle AgedAnti-Bacterial AgentsSurgeryUrinary Incontinence030220 oncology & carcinogenesisUrinary Tract InfectionsCohortUrinary Sphincter ArtificialFemalebusinessCohort studyUrology
researchProduct

Lower Urinary Tract Symptoms: What's New in Medical Treatment?

2018

Abstract Context Pharmacological treatment is a cornerstone in the management of patients with lower urinary tract symptoms (LUTS). Objective To review emerging evidence in the medical treatment of LUTS. Evidence acquisition An Embase/Pubmed-based literature search was conducted in December 2017, screening for randomized controlled trials (RCTs), prospective and retrospective series, animal model studies, and reviews on medical treatment of LUTS. Evidence synthesis The main medical innovation in recent years in overactive bladder (OAB) has been the approval of the first β 3 -adrenoceptor agonists (mirabegron) and intradetrusor onabotulinum toxin A, while several other drugs such as antiepil…

Malemedicine.medical_specialtyReceptors VasopressinUrologyUrinary Bladder030232 urology & nephrologyUrologyProstatic HyperplasiaUrinary incontinenceAdrenergic beta-3 Receptor Agonistsurologic and male genital diseases03 medical and health sciences0302 clinical medicineLower Urinary Tract SymptomsLower urinary tract symptomsmedicineDesmopressin AcetateNocturiaHumansDeamino Arginine VasopressinProspective StudiesBotulinum Toxins Type ADesmopressinRandomized Controlled Trials as TopicRetrospective StudiesUrinary bladderbusiness.industryUrinary Bladder OveractiveAntidiuretic AgentsPhosphodiesterase 5 Inhibitorsmedicine.diseasefemale genital diseases and pregnancy complicationsThiazolesmedicine.anatomical_structureOveractive bladderClinical Trials Phase III as Topic030220 oncology & carcinogenesisModels AnimalAcetanilidesFemaleNocturiamedicine.symptomMirabegronbusinessmedicine.drugEuropean urology focus
researchProduct

Xerostomia, thirst, sodium gradient and inter-dialytic weight gain in hemodialysis diabetic vs. non-diabetic patients

2017

Background In hemodialysis (HD) patients, xerostomia and hyposalivation may intensify sensations of thirst, and contribute to the intake of fluids and excessive inter-dialytic weight gain (IWG). Since IWG is regarded to be higher in diabetic patients than in non-diabetics HD enhancing their mortality, it is crucial to define plausible underlying causes. Therefore, the study investigates factors contributing to the increased IWG in diabetic HD patients. Material and Methods The study included 97 HD patients (38 diabetics) receiving hemodialysis. All participants completed surveys comprising the Dialysis Thirst Inventory (DTI) and Xerostomia Inventory. Unstimulated whole saliva flow rate (USW…

Malemedicine.medical_specialtySalivaSodiummedicine.medical_treatment030232 urology & nephrologychemistry.chemical_elementWeight GainGastroenterologyXerostomiaThirst03 medical and health sciences0302 clinical medicineRenal DialysisInternal medicineDiabetes mellitusMedicineHumansDiabetic NephropathiesGeneral DentistryDialysisbusiness.industryResearchSodium030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseMedically compromised patients in DentistryOtorhinolaryngologychemistryConcomitantUNESCO::CIENCIAS MÉDICASKidney Failure ChronicSurgeryFemaleHemodialysismedicine.symptombusinessWeight gainThirst
researchProduct

Artificial Urinary Sphincter Cuff Size Predicts Outcome in Male Patients Treated for Stress Incontinence: Results of a Large Central European Multice…

2019

Purpose The aim was to study the correlation between cuff size and outcome after implantation of an AMS 800 artificial urinary sphincter. Methods A total of 473 male patients with an AMS 800 sphincter implanted between 2012 and 2014 were analyzed in a retrospective multicenter cohort study performed as part of the Central European Debates on Male Incontinence (DOMINO) Project. Results Single cuffs were implanted in 54.5% and double cuffs in 45.5% of the patients. The cuffs used had a median circumference of 4.5 cm. Within a median follow of 18 months, urethral erosion occurred in 12.8% of the cases and was associated significantly more often with small cuff sizes (P<0.001). Multivariate ana…

Malemedicine.medical_specialtyStress incontinenceUrologySingle or double cuff030232 urology & nephrologylcsh:RC870-923Erosion rateArtificial urinary sphincter03 medical and health sciences0302 clinical medicineMedicineClinical InvestigationRisk factorAMS 800030219 obstetrics & reproductive medicineStress urinary incontinencebusiness.industryArtificial urinary sphincterlcsh:Diseases of the genitourinary system. Urologymedicine.diseaseCuff sizeSurgerymedicine.anatomical_structureNeurologyMale patientCuffSphincterOriginal ArticleNeurology (clinical)businessCohort studyInternational Neurourology Journal
researchProduct

Risk Factors for Failure of Male Slings and Artificial Urinary Sphincters: Results from a Large Middle European Cohort Study.

2016

&lt;b&gt;&lt;i&gt;Introduction:&lt;/i&gt;&lt;/b&gt; We analysed the impact of predefined risk factors: age, diabetes, history of pelvic irradiation, prior surgery for stress urinary incontinence (SUI), prior urethral stricture, additional procedure during SUI surgery, duration of incontinence, ASA-classification and cause for incontinence on failure and complications in male SUI surgery. &lt;b&gt;&lt;i&gt;Materials and Methods:&lt;/i&gt;&lt;/b&gt; We retrospectively identified 506 patients with an artificial urinary sphincter (AUS) and 513 patients with a male sling (MS) in a multicenter cohort study. Complication rates were correlated to the risk factors in univariate analysis. Subsequentl…

Malemedicine.medical_specialtyTime FactorsUrologic Surgical Procedures MaleUrethral strictureUrologyUrinary Incontinence Stress030232 urology & nephrologyUrologyUrinary incontinenceKaplan-Meier EstimateProsthesis DesignDisease-Free SurvivalArtificial urinary sphincter03 medical and health sciences0302 clinical medicineRisk FactorsmedicineOdds RatioHumansTreatment FailureRisk factorAgedRetrospective StudiesUnivariate analysisSuburethral SlingsChi-Square Distributionbusiness.industryRetrospective cohort studyOdds ratioMiddle Agedmedicine.diseaseProsthesis FailureEuropeLogistic Models030220 oncology & carcinogenesisMultivariate AnalysisUrinary Sphincter Artificialmedicine.symptombusinessCohort studyUrologia internationalis
researchProduct

The TiLOOP® Male Sling: Did We Forejudge.

2017

&lt;b&gt;&lt;i&gt;Introduction:&lt;/i&gt;&lt;/b&gt; To evaluate the safety and efficacy of the TiLOOP® male sling (pfm medical, Cologne, Germany) used in the treatment for male stress urinary incontinence (SUI). &lt;b&gt;&lt;i&gt;Material and Methods:&lt;/i&gt;&lt;/b&gt; We retrospectively evaluated a total of 34 patients with a TiLOOP® male sling. Perioperative complication rates were assessed and validated questionnaires were prospectively evaluated to assess quality of life and satisfaction rate. Outcome and complication rates were analysed by using descriptive statistics. Correlation of continence outcome and risk factors was performed with the chi-square test. A &lt;i&gt;p&lt;/i&gt; va…

Malemedicine.medical_specialtyTime FactorsUrologic Surgical Procedures MaleUrologyUrinary Incontinence Stress030232 urology & nephrologyUrinary incontinenceProsthesis Design03 medical and health sciences0302 clinical medicinePatient satisfactionPostoperative ComplicationsQuality of lifeRisk FactorsSurveys and QuestionnairesmedicineHumansAgedRetrospective StudiesAged 80 and overSuburethral SlingsChi-Square Distributionbusiness.industryRetrospective cohort studyPerioperativeRecovery of FunctionMiddle AgedSurgeryUrodynamicsTreatment OutcomePatient Satisfaction030220 oncology & carcinogenesisCohortQuality of Lifemedicine.symptomComplicationbusinessChi-squared distributionUrologia internationalis
researchProduct